netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB researchers honored with 2018 António Champalimaud Vision Award

Prestigious award is for the scientists’ work, which led to the first gene therapy for an inherited disease.

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research, which collectively led to the development and 2017 FDA approval of Luxturnaä, a successful treatment for a type of Leber congenital amaurosis (LCA).  LCA is a genetic cause of childhood blindness.  Their work also demonstrated the potential for future developments in gene therapy for other inherited diseases, and led to the first gene therapy for an inherited human disease.  The RPB-associated awardees include: 

  • Jean Bennett, MD PhD, FARVO, of the University of Pennsylvania School of Medicine. Bennett is the recipient of multiple awards from RPB, including a Career Development Award (1992), Special Scholar Award (2000), Lew R. Wasserman Merit Award (2004) and Senior Scientific Investigator Award (2007).
  • Albert Maguire, MD, of the Children's Hospital of Philadelphia, who received RPB’s Physician-Scientist Award in 2001.
  • Samuel Jacobson, MD, PhD, of the Scheie Eye Institute, University of Pennsylvania School of Medicine, 2000 recipient of the RPB Senior Scientific Investigator Award.
  • William Hauswirth, PhD, of the University of Florida College of Medicine, who received the Senior Scientific Investigator Award in 1997.
  • Robin Ali, PhD, FMedSci, of the Institute of Ophthalmology of the University College of London. Ali has been a member of the RPB Scientific Advisory Panel since 2015.

The five – and two others who will receive the Champalimaud Award – will share a 1 million Euro prize.  The awardees will also present a special lecture at ARVO 2019 in Vancouver.

The António Champalimaud Vision Award is supported by Vision 2020 - The Right to Sight, a global blindness-prevention initiative launched in collaboration with the World Health Organization and the International Agency for the Prevention of Blindness.

 lEARN MORE ABOUT THE AWARD

 

Related News: Feature Story, For the Media, Gene Therapy, Top Story

rpb logo

Research to Prevent Blindness and American Academy of Ophthalmology Award Grants for Big Data Research to Improve Patient Care

Award recipients to use IRIS Registry database to improve diagnosis and treatment of eye disease

Read More

 
RPB logo

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2022 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research.

Read More

 
William vanden Heuvel

In Memoriam: William J. vanden Heuvel

The RPB Board Member, who was a U.S. Ambassador, lawyer, and champion of human rights, worked tirelessly for causes he believed in.

Read More

 
Photo of eye
Watch The Video

RPB HOSTS VIRTUAL EVENT ON LOW VISION

The online event featured RPB grantees and is now available to view on demand.

Read More

 
RPB logo

Research to Prevent Blindness and The Glaucoma Foundation Offer Critical Funding for Early-Career Vision Scientists

The Career Advancement Awards—one focused specifically on glaucoma research—support novel science related to eye diseases by up-and-coming researchers.

Read More

 
Event photo
Watch The Video

RPB Hosts Virtual Event On Diabetic Retinopathy

RPB grantees provide expert advice on DR as part of the "Lunch & Learn" series.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.